GI upset is the most common side effect with GLP-1/GIP agonist therapy, and the incidence of these side effects is similar between tirzepadite and semaglutide in randomized control trials
Lab results help confirm youre a good candidate and may also be required for insurance approval
[DOI] [PubMed] [Google Scholar] [51].Tran KTM, Gavitt TD, Farrell NJ, Curry EJ, Mara AB, Patel A, Brown L, Kilpatrick S, Piotrowska R, Mishra N, Szczepanek SM, Nguyen TD, Transdermal microneedles for the programmable burst release of multiple vaccine payloads, Nature Biomedical Engineering 5(9) (2021) 9981007
Insurance Coverage : A lack of appropriate insurance plans may impede the expansion of the GLP-1 Agonists market
GLP-1 also acts as a satiety signal by activating receptors on vagal afferent neurons that transmit signals from the gut to the hypothalamic satiety centers, including regions that regulate appetite, energy expenditure, and food reward
Fatigue that sleep does not fix